Randomized trial of surgery versus radiotherapy in patients with stage IIIA (N2) non small-cell lung cancer after a response to induction chemotherapy. EORTC 08941.
作者： T.A.W. Splinter , P.E. van Schil , G.W.P.M. Kramer , J. van Meerbeeck , A. Gregor
关键词: Stage IIIa 、 Oncology 、 Medicine 、 Cancer 、 Stage (cooking) 、 Internal medicine 、 Chemotherapy 、 Randomized controlled trial 、 Lung cancer 、 Surgery 、 Radiation therapy 、 Induction chemotherapy
摘要: Combined modality treatment of patients with stage III non small-cell lung cancer (NSCLC) has recently become widely accepted. Standard combinations are neoadjuvant chemotherapy followed by radiotherapy or concurrent and radiotherapy. The effect combined on survival is dependent both the efficacy to eradicate micrometastases optimal local control. European Organization for Research Treatment Cancer (EORTC) Lung Cooperative Group chosen investigate in a comparative way side effects versus surgery IIIA (N2) NSCLC.
ulb.ac.be
metapress.com参考文章(16)
David J. Sugarbaker, James Herndon, Leslie J. Kohman, Mark J. Krasna, Mark R. Green, Results of cancer and leukemia group B protocol 8935 ☆ ☆☆ ★ ★★ ♢ ♢♢ ♦: A multiinstitutional phase II trimodality trial for stage IIIa (N2) non-small-cell lung cancer The Journal of Thoracic and Cardiovascular Surgery. ,vol. 109, pp. 473- 485 ,(1995) , 10.1016/S0022-5223(95)70278-4
K S Albain, V W Rusch, J J Crowley, T W Rice, A T Turrisi, J K Weick, V A Lonchyna, C A Presant, R J McKenna, D R Gandara, Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. Journal of Clinical Oncology. ,vol. 13, pp. 1880- 1892 ,(1995) , 10.1200/JCO.1995.13.8.1880
N C Choi, R W Carey, W Daly, D Mathisen, J Wain, C Wright, T Lynch, M Grossbard, H Grillo, Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer Journal of Clinical Oncology. ,vol. 15, pp. 712- 722 ,(1997) , 10.1200/JCO.1997.15.2.712
W Eberhardt, H Wilke, G Stamatis, M Stuschke, A Harstrick, H Menker, B Krause, M R Müeller, M Stahl, M Flasshove, V Budach, D Greschuchna, N Konietzko, H Sack, S Seeber, Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. Journal of Clinical Oncology. ,vol. 16, pp. 622- 634 ,(1998) , 10.1200/JCO.1998.16.2.622
B Jeremic, Y Shibamoto, L Acimovic, L Djuric, Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. Journal of Clinical Oncology. ,vol. 13, pp. 452- 458 ,(1995) , 10.1200/JCO.1995.13.2.452
R L Burkes, R J Ginsberg, F A Shepherd, M E Blackstein, M E Goldberg, P F Waters, G A Patterson, T Todd, F G Pearson, J D Cooper, Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial. Journal of Clinical Oncology. ,vol. 10, pp. 580- 586 ,(1992) , 10.1200/JCO.1992.10.4.580
Jack A Roth, E.Neely Atkinson, Frank Fossella, Ritsuko Komaki, M.Bernadette Ryan, J.B Putnam, Jin Soo Lee, Hari Dhingra, Louis De Caro, Marvin Chasen, Waun Ki Hong, Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer Lung Cancer. ,vol. 21, pp. 1- 6 ,(1998) , 10.1016/S0169-5002(98)00046-4
Clifton F. Mountain, A new international staging system for lung cancer Chest. ,vol. 89, pp. 225- 233 ,(1986) , 10.1378/CHEST.89.4_SUPPLEMENT.225S
Clifton F. Mountain, Revisions in the International System for Staging Lung Cancer Chest. ,vol. 111, pp. 1710- 1717 ,(1997) , 10.1378/CHEST.111.6.1710
Michele Saunders, Stanley Dische, Ann Barrett, Angela Harvey, Della Gibson, Mahesh Parmar, Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial The Lancet. ,vol. 350, pp. 161- 165 ,(1997) , 10.1016/S0140-6736(97)06305-8